Skip to main content
An official website of the United States government
Grant Details

Grant Number: 1R01CA157744-01 Interpret this number
Primary Investigator: King, Mary-Claire
Organization: University Of Washington
Project Title: Discovery of New Genes for Inherited Predisposition to Breast Cancer By Exome Seq
Fiscal Year: 2011


Abstract

DESCRIPTION (provided by applicant): The goal of this project is to identify new genes for inherited susceptibility to breast cancer. DNA capture and massively parallel sequencing technologies will be exploited to identify these genes in a cohort of 1822 families, each with at least four relatives with breast cancer. The genetic causes of breast cancer in more than 1500 of these families remain unresolved. Discovery of new breast cancer genes in these families involves three aims. In AIM 1, all known genes for inherited predisposition to breast cancer will be fully sequenced in all affected relatives from 150 of the families. The probands of all unresolved families have wildtype sequences at BRCA1, BRCA2, CHEK2, PALB2, CHEK2, BRIP1, p53, and PTEN. However, other affected family members may carry mutations in these genes, and the proband may be a sporadic case. Constitutional DNA of affected relatives will be used to prepare paired-end libraries, which will be hybridized to custom oligonucleotide pools to capture all known breast cancer susceptibility genes, then the enriched libraries will be bar-coded and sequenced in a multiplex design on an Illumina GAIIx genome analyzer. Mutations will be validated by Sanger sequencing. In AIM 2, the Illumina platform will be used again, to fully sequence the entire exomes of all women in the screen with wildtype sequences at all known breast cancer genes. Variants will be filtered to identify rare nonsense mutations, frameshifts, splice site mutations, and genomic deletions and duplications that disrupt genes. Filtered mutations will be validated and tested for co-inheritance with breast cancer. Multiple deleterious mutations are a hallmark of all known genes for inherited breast cancer and are the strongest proof of functional consequence of new breast cancer genes. In Aim 3A, the most promising candidate genes will be fully sequenced in DNA samples from an independent series of familial breast cancer patients to reveal additional mutations. In Aim 3B, potentially functional mutations in these genes will be genotyped by TaqMan assays in large follow-up series to estimate individual and gene-wide mutation frequencies and relative risks. Discovery of new breast cancer susceptibility genes will allow prevention strategies to be extended to families for which causal genes are currently unknown, to better identify women at risk, to allow closer medical surveillance of these women, to stimulate design of new prevention strategies based on genetic evidence, and to offer a better understanding of the biological pathways involved in breast cancer development. PUBLIC HEALTH RELEVANCE: The goal of this project is to identify new genes for inherited susceptibility to breast cancer using DNA capture and next generation sequencing technologies. Discovery of new breast cancer susceptibility genes will allow prevention strategies to be extended to families for which causal genes are currently unknown.



Publications

Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: an NRG Oncology/Gynecologic Oncology Group Study.
Authors: Norquist B.M. , Brady M.F. , Harrell M.I. , Walsh T. , Lee M.K. , Gulsuner S. , Bernards S.S. , Casadei S. , Burger R.A. , Tewari K.S. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2017-11-30 00:00:00.0; , .
EPub date: 2017-11-30 00:00:00.0.
PMID: 29191972
Related Citations

Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
Authors: Lolas Hamameh S. , Renbaum P. , Kamal L. , Dweik D. , Salahat M. , Jaraysa T. , Abu Rayyan A. , Casadei S. , Mandell J.B. , Gulsuner S. , et al. .
Source: International Journal Of Cancer, 2017-08-15 00:00:00.0; 141(4), p. 750-756.
EPub date: 2017-05-19 00:00:00.0.
PMID: 28486781
Related Citations

MYO3A Causes Human Dominant Deafness and Interacts with Protocadherin 15-CD2 Isoform.
Authors: Grati M. , Yan D. , Raval M.H. , Walsh T. , Ma Q. , Chakchouk I. , Kannan-Sundhari A. , Mittal R. , Masmoudi S. , Blanton S.H. , et al. .
Source: Human Mutation, 2016 May; 37(5), p. 481-7.
EPub date: 2016-02-16 00:00:00.0.
PMID: 26841241
Related Citations

Inherited Mutations in Women With Ovarian Carcinoma.
Authors: Norquist B.M. , Harrell M.I. , Brady M.F. , Walsh T. , Lee M.K. , Gulsuner S. , Bernards S.S. , Casadei S. , Yi Q. , Burger R.A. , et al. .
Source: Jama Oncology, 2016 Apr; 2(4), p. 482-90.
PMID: 26720728
Related Citations

Inherited predisposition to breast cancer among African American women.
Authors: Churpek J.E. , Walsh T. , Zheng Y. , Moton Z. , Thornton A.M. , Lee M.K. , Casadei S. , Watts A. , Neistadt B. , Churpek M.M. , et al. .
Source: Breast Cancer Research And Treatment, 2015 Jan; 149(1), p. 31-9.
PMID: 25428789
Related Citations

Precision medicine meets public health: population screening for BRCA1 and BRCA2.
Authors: Levy-Lahad E. , Lahad A. , King M.C. .
Source: Journal Of The National Cancer Institute, 2015 Jan; 107(1), p. 420.
PMID: 25550384
Related Citations

Mutations in Twinkle primase-helicase cause Perrault syndrome with neurologic features.
Authors: Morino H. , Pierce S.B. , Matsuda Y. , Walsh T. , Ohsawa R. , Newby M. , Hiraki-Kamon K. , Kuramochi M. , Lee M.K. , Klevit R.E. , et al. .
Source: Neurology, 2014-11-25 00:00:00.0; 83(22), p. 2054-61.
EPub date: 2014-10-29 00:00:00.0.
PMID: 25355836
Related Citations

Deep sequencing with intronic capture enables identification of an APC exon 10 inversion in a patient with polyposis.
Authors: Shirts B.H. , Salipante S.J. , Casadei S. , Ryan S. , Martin J. , Jacobson A. , Vlaskin T. , Koehler K. , Livingston R.J. , King M.C. , et al. .
Source: Genetics In Medicine : Official Journal Of The American College Of Medical Genetics, 2014 Oct; 16(10), p. 783-6.
PMID: 24675673
Related Citations

Lasker Award winner Mary-Claire King.
Authors: King M.C. .
Source: Nature Medicine, 2014 Oct; 20(10), p. 1124-5.
PMID: 25295950
Related Citations

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Authors: Gabai-Kapara E. , Lahad A. , Kaufman B. , Friedman E. , Segev S. , Renbaum P. , Beeri R. , Gal M. , Grinshpun-Cohen J. , Djemal K. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2014-09-30 00:00:00.0; 111(39), p. 14205-10.
EPub date: 2014-09-30 00:00:00.0.
PMID: 25192939
Related Citations

Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award.
Authors: King M.C. , Levy-Lahad E. , Lahad A. .
Source: Jama, 2014-09-17 00:00:00.0; 312(11), p. 1091-2.
PMID: 25198398
Related Citations

Breast-cancer risk in families with mutations in PALB2.
Authors: Antoniou A.C. , Casadei S. , Heikkinen T. , Barrowdale D. , Pylkäs K. , Roberts J. , Lee A. , Subramanian D. , De Leeneer K. , Fostira F. , et al. .
Source: The New England Journal Of Medicine, 2014-08-07 00:00:00.0; 371(6), p. 497-506.
PMID: 25099575
Related Citations

"The race" to clone BRCA1.
Authors: King M.C. .
Source: Science (new York, N.y.), 2014-03-28 00:00:00.0; 343(6178), p. 1462-5.
PMID: 24675952
Related Citations

Germline mutations of inhibins in early-onset ovarian epithelial tumors.
Authors: Tournier I. , Marlin R. , Walton K. , Charbonnier F. , Coutant S. , Théry J.C. , Charbonnier C. , Spurrell C. , Vezain M. , Ippolito L. , et al. .
Source: Human Mutation, 2014 Mar; 35(3), p. 294-7.
PMID: 24302632
Related Citations

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Authors: Pennington K.P. , Walsh T. , Harrell M.I. , Lee M.K. , Pennil C.C. , Rendi M.H. , Thornton A. , Norquist B.M. , Casadei S. , Nord A.S. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2014-02-01 00:00:00.0; 20(3), p. 764-75.
EPub date: 2014-02-01 00:00:00.0.
PMID: 24240112
Related Citations

Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.
Authors: Pritchard C.C. , Salipante S.J. , Koehler K. , Smith C. , Scroggins S. , Wood B. , Wu D. , Lee M.K. , Dintzis S. , Adey A. , et al. .
Source: The Journal Of Molecular Diagnostics : Jmd, 2014 Jan; 16(1), p. 56-67.
PMID: 24189654
Related Citations

A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencing.
Authors: Pritchard C.C. , Smith C. , Marushchak T. , Koehler K. , Holmes H. , Raskind W. , Walsh T. , Bennett R.L. .
Source: Genetics In Medicine : Official Journal Of The American College Of Medical Genetics, 2013 Dec; 15(12), p. 1004-7.
PMID: 23619277
Related Citations

Formation of chimeric genes by copy-number variation as a mutational mechanism in schizophrenia.
Authors: Rippey C. , Walsh T. , Gulsuner S. , Brodsky M. , Nord A.S. , Gasperini M. , Pierce S. , Spurrell C. , Coe B.P. , Krumm N. , et al. .
Source: American Journal Of Human Genetics, 2013-10-03 00:00:00.0; 93(4), p. 697-710.
PMID: 24094746
Related Citations

Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network.
Authors: Gulsuner S. , Walsh T. , Watts A.C. , Lee M.K. , Thornton A.M. , Casadei S. , Rippey C. , Shahin H. , Consortium on the Genetics of Schizophrenia (COGS) , PAARTNERS Study Group , et al. .
Source: Cell, 2013-08-01 00:00:00.0; 154(3), p. 518-29.
PMID: 23911319
Related Citations

Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease.
Authors: Jenkinson E.M. , Rehman A.U. , Walsh T. , Clayton-Smith J. , Lee K. , Morell R.J. , Drummond M.C. , Khan S.N. , Naeem M.A. , Rauf B. , et al. .
Source: American Journal Of Human Genetics, 2013-04-04 00:00:00.0; 92(4), p. 605-13.
EPub date: 2013-03-28 00:00:00.0.
PMID: 23541340
Related Citations

Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing.
Authors: Norquist B.M. , Pennington K.P. , Agnew K.J. , Harrell M.I. , Pennil C.C. , Lee M.K. , Casadei S. , Thornton A.M. , Garcia R.L. , Walsh T. , et al. .
Source: Gynecologic Oncology, 2013 Mar; 128(3), p. 483-7.
PMID: 23262210
Related Citations

Mutation of the ATP-gated P2X(2) receptor leads to progressive hearing loss and increased susceptibility to noise.
Authors: Yan D. , Zhu Y. , Walsh T. , Xie D. , Yuan H. , Sirmaci A. , Fujikawa T. , Wong A.C. , Loh T.L. , Du L. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2013-02-05 00:00:00.0; 110(6), p. 2228-33.
EPub date: 2013-01-23 00:00:00.0.
PMID: 23345450
Related Citations

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
Authors: Pennington K.P. , Walsh T. , Lee M. , Pennil C. , Novetsky A.P. , Agnew K.J. , Thornton A. , Garcia R. , Mutch D. , King M.C. , et al. .
Source: Cancer, 2013-01-15 00:00:00.0; 119(2), p. 332-8.
EPub date: 2013-01-15 00:00:00.0.
PMID: 22811390
Related Citations

Loss of function germline mutations in RAD51D in women with ovarian carcinoma.
Authors: Wickramanayake A. , Wickramanyake A. , Bernier G. , Pennil C. , Casadei S. , Agnew K.J. , Stray S.M. , Mandell J. , Garcia R.L. , Walsh T. , et al. .
Source: Gynecologic Oncology, 2012 Dec; 127(3), p. 552-5.
PMID: 22986143
Related Citations

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.
Authors: Pritchard C.C. , Smith C. , Salipante S.J. , Lee M.K. , Thornton A.M. , Nord A.S. , Gulden C. , Kupfer S.S. , Swisher E.M. , Bennett R.L. , et al. .
Source: The Journal Of Molecular Diagnostics : Jmd, 2012 Jul; 14(4), p. 357-66.
PMID: 22658618
Related Citations

Response to DNA damage of CHEK2 missense mutations in familial breast cancer.
Authors: Roeb W. , Higgins J. , King M.C. .
Source: Human Molecular Genetics, 2012-06-15 00:00:00.0; 21(12), p. 2738-44.
EPub date: 2012-06-15 00:00:00.0.
PMID: 22419737
Related Citations

A Truncating Mutation In Gpsm2 Is Associated With Recessive Non-syndromic Hearing Loss
Authors: Yariz,K.O. , Walsh,T. , Akay,H. , Duman,D. , Akkaynak,A.C. , King,M.C. , Tekin,M. .
Source: Clinical Genetics, 2012 Mar; 81(3), p. 289-93.
PMID: 21348867
Related Citations

A genomewide screen for suppressors of Alu-mediated rearrangements reveals a role for PIF1.
Authors: Chisholm K.M. , Aubert S.D. , Freese K.P. , Zakian V.A. , King M.C. , Welcsh P.L. .
Source: Plos One, 2012; 7(2), p. e30748.
PMID: 22347400
Related Citations

Garrod's fourth inborn error of metabolism solved by the identification of mutations causing pentosuria.
Authors: Pierce S.B. , Spurrell C.H. , Mandell J.B. , Lee M.K. , Zeligson S. , Bereman M.S. , Stray S.M. , Fokstuen S. , MacCoss M.J. , Levy-Lahad E. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2011-11-08 00:00:00.0; 108(45), p. 18313-7.
EPub date: 2011-11-08 00:00:00.0.
PMID: 22042873
Related Citations

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Authors: Walsh T. , Casadei S. , Lee M.K. , Pennil C.C. , Nord A.S. , Thornton A.M. , Roeb W. , Agnew K.J. , Stray S.M. , Wickramanayake A. , et al. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2011-11-01 00:00:00.0; 108(44), p. 18032-7.
EPub date: 2011-11-01 00:00:00.0.
PMID: 22006311
Related Citations

Mutations In Mitochondrial Histidyl Trna Synthetase Hars2 Cause Ovarian Dysgenesis And Sensorineural Hearing Loss Of Perrault Syndrome
Authors: Pierce,S.B. , Chisholm,K.M. , Lynch,E.D. , Lee,M.K. , Walsh,T. , Opitz,J.M. , Li,W. , Klevit,R.E. , King,M.C. .
Source: Proceedings Of The National Academy Of Sciences Of The United States Of America, 2011-04-19 00:00:00.0; 108(16), p. 6543-8.
PMID: 21464306
Related Citations

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Authors: Casadei S. , Norquist B.M. , Walsh T. , Stray S. , Mandell J.B. , Lee M.K. , Stamatoyannopoulos J.A. , King M.C. .
Source: Cancer Research, 2011-03-15 00:00:00.0; 71(6), p. 2222-9.
EPub date: 2011-03-15 00:00:00.0.
PMID: 21285249
Related Citations



Back to Top